Ad
DYN Short Information Dyne Therapeutics Inc.
Short Information | Dyne Therapeutics Inc. (NASDAQ:DYN)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 9,714,180 |
| Total Actual Volume | 49,323,760 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 485,709 |
| Average Short Percentage | 21.62% |
Is there a DYN Short Squeeze or Breakout about to happen?
See the DYN Short Analysis for free Sign up or Login
Powered by Squeeze Report
DYN Twenty Trading Day's Volume to Short Volume Chart
DYN Twenty Trading Day Price Chart
DYN Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 06-18-2025 | $10.79 | $10.78 | $11.1829 | $10.5901 | 3,007,806 | 372,661 | 12.39% |
| 06-17-2025 | $12.512 | $10.86 | $12.99 | $10.56 | 6,712,801 | 1,275,953 | 19.01% |
| 06-16-2025 | $14.47 | $13.82 | $14.61 | $13.715 | 7,062,838 | 423,369 | 5.99% |
| 06-13-2025 | $14 | $14.41 | $14.64 | $13.8 | 1,747,992 | 498,126 | 28.5% |
| 06-12-2025 | $14.29 | $14.46 | $14.84 | $13.98 | 2,504,531 | 430,738 | 17.2% |
| 06-11-2025 | $14.73 | $14.57 | $15.23 | $14.465 | 1,594,260 | 411,738 | 25.83% |
| 06-10-2025 | $14.53 | $14.78 | $15.12 | $14.28 | 2,524,507 | 519,774 | 20.59% |
| 06-09-2025 | $15.2 | $14.4 | $15.21 | $14.02 | 3,622,151 | 941,980 | 26.01% |
| 06-06-2025 | $14.15 | $14.7 | $15.01 | $14.03 | 2,674,392 | 645,553 | 24.14% |
| 06-05-2025 | $13.29 | $13.99 | $14.24 | $13.14 | 2,458,875 | 472,763 | 19.23% |
| 06-04-2025 | $13.29 | $13.41 | $14 | $13.19 | 1,975,361 | 452,357 | 22.9% |
| 06-03-2025 | $12.82 | $13.27 | $13.59 | $12.54 | 1,752,594 | 396,258 | 22.61% |
| 06-02-2025 | $11.96 | $12.7 | $12.93 | $11.92 | 2,219,105 | 705,937 | 31.81% |
| 05-30-2025 | $12.02 | $11.96 | $12.0971 | $11.51 | 1,132,995 | 204,220 | 18.02% |
| 05-29-2025 | $12.15 | $12.24 | $12.34 | $11.67 | 1,579,093 | 414,163 | 26.23% |
| 05-28-2025 | $11.73 | $11.76 | $11.99 | $11.52 | 871,450 | 156,346 | 17.94% |
| 05-27-2025 | $12.07 | $11.7 | $12.2521 | $11.63 | 1,095,642 | 238,559 | 21.77% |
| 05-23-2025 | $11.46 | $11.69 | $11.78 | $11.225 | 1,469,291 | 374,573 | 25.49% |
| 05-22-2025 | $11.63 | $11.9 | $12.45 | $11.54 | 1,744,243 | 450,850 | 25.85% |
| 05-21-2025 | $12.07 | $11.76 | $12.17 | $11.44 | 1,573,833 | 328,262 | 20.86% |
News, Short Squeeze, Breakout and More Instantly...
Dyne Therapeutics Inc. Company Name:
DYN Stock Symbol:
NASDAQ Market:
0.0% G/L:
$10.78 Last:
3,007,806 Volume:
$10.79 Open:
$10.78 Close:
Dyne Therapeutics Inc. Website:
Ad
-
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of clinical benefit with DYNE-101 in DM...
-
WALTHAM, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced it plans to provide a...
-
- DYNE-302 Demonstrated Functional Improvement in an FSHD Preclinical Model - WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven n...